Boston Scientific Corp (BSX)

Operating profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	2,343,000	2,161,000	1,826,000	1,735,000	1,649,000	1,427,000	1,456,000	1,295,000	1,199,000	1,069,000	477,000	144,000	-80,000	80,000	668,000	1,123,000	1,518,000	1,627,000	1,632,000	1,640,000
Revenue (ttm)	US$ in thousands	13,974,000	10,508,000	10,348,000	9,999,000	9,228,000	12,104,000	11,689,000	11,502,000	11,625,000	11,168,000	10,855,000	9,774,000	9,553,000	9,751,000	9,790,000	10,420,000	10,349,000	10,035,000	9,758,000	9,649,000
Operating profit margin		16.77%	20.57%	17.65%	17.35%	17.87%	11.79%	12.46%	11.26%	10.31%	9.57%	4.39%	1.47%	-0.84%	0.82%	6.82%	10.78%	14.67%	16.21%	16.72%	17.00%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $2,343,000K ÷ $13,974,000K
= 16.77%

The operating profit margin of Boston Scientific Corp. has shown a consistent and generally positive trend over the quarters provided, ranging from 15.71% to 16.97%. This indicates that the company has been effectively controlling its operating expenses relative to its revenue, resulting in a stable level of profitability. The gradual increase in the operating profit margin from 15.71% in Q2 2022 to 16.97% in Q4 2023 suggests improved operational efficiency and potentially better cost management measures implemented by the company. Overall, the steady and incremental improvement in the operating profit margin reflects positively on Boston Scientific Corp.'s ability to generate profits from its core business operations.